Literature DB >> 33386889

Hypoxia-induced alternative splicing in human diseases: the pledge, the turn, and the prestige.

Subhashis Natua1, Cheemala Ashok1, Sanjeev Shukla2.   

Abstract

Maintenance of oxygen homeostasis is an indispensable criterion for the existence of multicellular life-forms. Disruption of this homeostasis due to inadequate oxygenation of the respiring tissues leads to pathological hypoxia, which acts as a significant stressor in several pathophysiological conditions including cancer, cardiovascular defects, bacterial infections, and neurological disorders. Consequently, the hypoxic tissues develop necessary adaptations both at the tissue and cellular level. The cellular adaptations involve a dramatic alteration in gene expression, post-transcriptional and post-translational modification of gene products, bioenergetics, and metabolism. Among the key responses to oxygen-deprivation is the skewing of cellular alternative splicing program. Herein, we discuss the current concepts of oxygen tension-dependent alternative splicing relevant to various pathophysiological conditions. Following a brief description of cellular response to hypoxia and the pre-mRNA splicing mechanism, we outline the impressive number of hypoxia-elicited alternative splicing events associated with maladies like cancer, cardiovascular diseases, and neurological disorders. Furthermore, we discuss how manipulation of hypoxia-induced alternative splicing may pose promising strategies for novel translational diagnosis and therapeutic interventions.

Entities:  

Keywords:  Alternative splicing; Cardiovascular disease; Hallmarks of cancer; Hypoxia; Neurodegenerative diseases; Splicing therapeutics

Mesh:

Substances:

Year:  2021        PMID: 33386889     DOI: 10.1007/s00018-020-03727-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  132 in total

1.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.

Authors:  G L Semenza; G L Wang
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

Review 2.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

Authors:  Charles J David; James L Manley
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

3.  Transcriptional regulation by hypoxia-inducible factor 1 molecular mechanisms of oxygen homeostasis.

Authors:  G L Semenza
Journal:  Trends Cardiovasc Med       Date:  1996-07       Impact factor: 6.677

Review 4.  Proline hydroxylation and gene expression.

Authors:  William G Kaelin
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

5.  Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression.

Authors:  Y Makino; R Cao; K Svensson; G Bertilsson; M Asman; H Tanaka; Y Cao; A Berkenstam; L Poellinger
Journal:  Nature       Date:  2001-11-29       Impact factor: 49.962

6.  Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein.

Authors:  M A Goldberg; S P Dunning; H F Bunn
Journal:  Science       Date:  1988-12-09       Impact factor: 47.728

7.  Hypoxia inducible factor 1alpha gene (HIF-1alpha) splice variants: potential prognostic biomarkers in breast cancer.

Authors:  Jean-Philippe Dales; Nathalie Beaufils; Monique Silvy; Christophe Picard; Vanessa Pauly; Vincent Pradel; Christine Formisano-Tréziny; Pascal Bonnier; Sophie Giusiano; Colette Charpin; Jean Gabert
Journal:  BMC Med       Date:  2010-07-12       Impact factor: 8.775

Review 8.  Hypoxia-inducible gene expression.

Authors:  J Fandrey
Journal:  Respir Physiol       Date:  1995-07

Review 9.  Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.

Authors:  William G Kaelin; Peter J Ratcliffe
Journal:  Mol Cell       Date:  2008-05-23       Impact factor: 17.970

10.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

Authors:  G L Wang; B H Jiang; E A Rue; G L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more
  5 in total

Review 1.  Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics.

Authors:  Qiu Peng; Yujuan Zhou; Linda Oyang; Nayiyuan Wu; Yanyan Tang; Min Su; Xia Luo; Ying Wang; Xiaowu Sheng; Jian Ma; Qianjin Liao
Journal:  Mol Ther       Date:  2021-11-15       Impact factor: 11.454

Review 2.  Functional RNA Dynamics Are Progressively Governed by RNA Destabilization during the Adaptation to Chronic Hypoxia.

Authors:  Rebekka Bauer; Sofie Patrizia Meyer; Karolina Anna Kloss; Vanesa Maria Guerrero Ruiz; Samira Reuscher; You Zhou; Dominik Christian Fuhrmann; Kathi Zarnack; Tobias Schmid; Bernhard Brüne
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

3.  Short-Term Hypoxia in Cells Induces Expression of Genes Which Are Enhanced in Stressed Cells.

Authors:  Inga Peciuliene; Egle Jakubauskiene; Laurynas Vilys; Ruta Zinkeviciute; Kotryna Kvedaraviciute; Arvydas Kanopka
Journal:  Genes (Basel)       Date:  2022-09-06       Impact factor: 4.141

4.  E2F1 and epigenetic modifiers orchestrate breast cancer progression by regulating oxygen-dependent ESRP1 expression.

Authors:  Cheemala Ashok; Neha Ahuja; Subhashis Natua; Jharna Mishra; Atul Samaiya; Sanjeev Shukla
Journal:  Oncogenesis       Date:  2021-08-06       Impact factor: 7.485

5.  Combined Quantitative (Phospho)proteomics and Mass Spectrometry Imaging Reveal Temporal and Spatial Protein Changes in Human Intestinal Ischemia-Reperfusion.

Authors:  Anna M Kip; Juan Manuel Valverde; Maarten Altelaar; Ron M A Heeren; Inca H R Hundscheid; Cornelis H C Dejong; Steven W M Olde Damink; Benjamin Balluff; Kaatje Lenaerts
Journal:  J Proteome Res       Date:  2021-12-07       Impact factor: 4.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.